Stem cell transplants can be a powerful tool to cure a number of life-threatening diseases. Before patients can receive such a transplant, they have to undergo intensive chemotherapy to remove all malignant cells of their own blood system. Unfortunately, many patients are unable to undergo this at all due to the severe side effects. Phire Therapeutics is developing a novel, innovative medicines that aim to target the malignant cells and thus replace chemotherapy to give patients the chance of a stem cell transplant and a potential cure.
Read more about Phire Therapeutics in the ETH news.